Hasil Pencarian - Matthias Moser
- Menampilkan 1 - 6 hasil dari 6
-
1
-
2
-
3
Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI. oleh Philipp M Kazmierczak, Egon Burian, Ralf Eschbach, Heidrun Hirner-Eppeneder, Matthias Moser, Lukas Havla, Michel Eisenblätter, Maximilian F Reiser, Konstantin Nikolaou, Clemens C Cyran
Diterbitkan 2015-01-01Dapatkan teks lengkap
Artikel -
4
Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immuno... oleh Ralf Stefan Eschbach, Dirk-Andre Clevert, Heidrun Hirner-Eppeneder, Michael Ingrisch, Matthias Moser, Jessica Schuster, Dina Tadros, Moritz Schneider, Philipp Maximilian Kazmierczak, Maximilian Reiser, Clemens C Cyran
Diterbitkan 2017-01-01Dapatkan teks lengkap
Artikel -
5
Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation. oleh Clemens C Cyran, Philipp M Kazmierczak, Heidrun Hirner, Matthias Moser, Michael Ingrisch, Lukas Havla, Alexandra Michels, Ralf Eschbach, Bettina Schwarz, Maximilian F Reiser, Christiane J Bruns, Konstantin Nikolaou
Diterbitkan 2013-01-01Dapatkan teks lengkap
Artikel -
6
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation. oleh Ralf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, Marcus Hacker, Axel Rominger, Janette Carlsen, Heidrun Hirner-Eppeneder, Jessica Schuster, Matthias Moser, Lukas Havla, Moritz J Schneider, Michael Ingrisch, Lukas Spaeth, Maximilian F Reiser, Konstantin Nikolaou, Clemens C Cyran
Diterbitkan 2015-01-01Dapatkan teks lengkap
Artikel